Long-Term Outcomes After PCI or CABG for Left Main Coronary Artery Disease According to Lesion Location

Junho Hyun1, Ju Hyeon Kim1, Yeongjin Jeong1

  • 1Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Insights

Coronary artery bypass grafting (CABG) is superior to percutaneous coronary intervention (PCI) for distal left main coronary artery bifurcation disease beyond five years. Outcomes were similar for ostial or shaft disease regardless of treatment.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Limited long-term comparative data exist for percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in left main coronary artery (LMCA) disease, specifically concerning lesion site.
  • Understanding lesion site impact is crucial for optimizing revascularization strategies in LMCA disease.

Purpose of the Study:

  • To investigate the influence of LMCA lesion location (ostial/shaft vs. distal bifurcation) on long-term outcomes following PCI or CABG.
  • To compare the efficacy and safety of PCI versus CABG based on LMCA lesion site.

Main Methods:

  • Analysis of patients from the MAIN-COMPARE registry comparing adverse outcomes between PCI and CABG.
  • Outcomes assessed included all-cause mortality and target vessel revascularization over a median follow-up of 12.0 years.
  • Stratification of analysis based on LMCA lesion location: ostial/shaft versus distal bifurcation.

Main Results:

  • For distal LMCA bifurcation disease, PCI demonstrated higher adjusted risks for death and a serious composite outcome compared to CABG, particularly after 5 years.
  • Drug-eluting stents (DES) showed progressively diverging risks for death and composite outcomes compared to CABG for distal bifurcation disease beyond 5 years.
  • No significant differences in outcomes were observed between PCI and CABG for ostial or shaft LMCA disease.

Conclusions:

  • CABG is associated with lower long-term mortality and serious composite outcome rates compared to DES for distal LMCA bifurcation disease.
  • For ostial or shaft LMCA disease, PCI and CABG demonstrate similar long-term safety and efficacy.
  • The findings highlight the importance of lesion site in guiding treatment decisions for LMCA disease.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
129
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
352
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
202
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
98
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
95
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
172